Safe and Effective Dosing of Basal–Bolus Insulin in Patients Receiving High-Dose Steroids for Hyper-Cyclophosphamide, Doxorubicin, Vincristine, and Dexamethasone Chemotherapy

Background: Hyperglycemia occurs in cancer patients receiving high-dose steroids with cyclophosphamide, doxorubicin, vincristine, and dexamethasone (hyper-CVAD) protocol. The purpose of our study was to determine insulin requirements in patients with hyperglycemia on hyper-CVAD therapy using a syste...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Technol Ther
Hlavní autoři: Brady, Veronica, Thosani, Sonali, Zhou, Shouhou, Bassett, Roland, Busaidy, Naifa Lamki, Lavis, Victor
Médium: Artigo
Jazyk:Inglês
Vydáno: Mary Ann Liebert, Inc. 2014
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4241952/
https://ncbi.nlm.nih.gov/pubmed/25321387
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dia.2014.0115
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky